TB Alliance Opposes United States’ Withdrawal from World Health Organization
NEW YORK (July 9, 2020)—TB Alliance supports recent commentaries including those in The Lancet and from the Global Health Council […]
Uncategorized
The Disease Fights Back: The Emergence of Extensively Drug-Resistant Tuberculosis
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
New Report Highlights Urgent Need for Improved Treatments for Children with MDR-TB
NEW YORK (June 18, 2020)—Children represent an estimated 11 percent of all tuberculosis (TB) cases, and about 1.1 million children
Standing Against Racism and Injustice
TB Alliance President and CEO Mel Spigelman, M.D. shared the following message to all TB Alliance employees and consultants in
InveniAI Announces Strategic Partnership with TB Alliance to Advance the Development of Transformative Therapies for Tuberculosis
Guilford, Conn., June 2, 2020, InveniAI® LLC, a global leader pioneering the application of artificial intelligence (AI) and machine learning
TB Alliance Commercialization Partner, Mylan, Launches Named Patient Access Program for New Highly Resistant TB Treatment
The NPAP is designed for patients in countries where regulatory approval or other access mechanisms for pretomanid are not yet
Revealing the Scope of TB Treatment in the Private Sector
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
A Conversation with Mitchell Warren
We spoke with Mitchell Warren, president of the TB Alliance Stakeholders Association (SHA) about what it means for TB Alliance
Unlocking the Combination: Generating Evidence for TB Drug Regimens
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
COVID-19: a message of solidarity on World TB Day 2020
Since 1982, those engaged in the fight against tuberculosis (TB) have observed 24 March as World TB Day, to commemorate